patients with nasopharyngeal cancer had an actuarial survival of 80 % at 30 months , whereas patients with squamous malignancies at other sites in the head and neck region had an actuarial survival of only 37 % .
C0153392
nasopharyngeal cancer
C0460004
head and neck region